FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.
Thompson Names Texas Health Official Head Of HHS Center For Faith-Based Initiatives.
Foundation Gives Duke $2M For Brain Tumor Research.
Democrats Say Bush Budget Neglects NSF And NASA.
Seattle Times, The Hutch Duel Over Five-Part Series.
NCI Offers Bibliography On Risk Communication.
SEER Program Expansion Through Cost-Sharing.
Toxicology Program Seeks Comment On Substances.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- How will FDA regulate psychedelics?
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The future of oncology: Early-career scientists need mentorship and a new academic model
- OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights









